On Oct 27, 2021 Immunai closed a Series B round and raised $215,000,000 from 8VC, Alexandria Venture Investments, Icon Ventures, Koch Disruptive Technologies, Piedmont Capital, […]
Series A – SimBioSys
On Oct 26, 2021 SimBioSys closed a Series A round and raised $15,000,000 from AV8 Ventures, Genoa Ventures, Heritage Group, Mayo Clinic, Northpond Ventures, featuring […]
Series A – Gencove
On Oct 26, 2021 Gencove closed a Series A round and raised $10,000,000 from Lewis & Clark AgriFood, Spero Ventures, Techammer, Third Kind Venture Capital, […]
Series B – Brave Health
On Oct 26, 2021 Brave Health closed a Series B round and raised $10,000,000 from Able Partners, City Light Capital, Union Square Ventures, featuring lead […]
Series A – Easyvet Clinic
On Oct 26, 2021 Easyvet Clinic closed a Series A round and raised $7,000,000 from Relevance Ventures (formerly Relevance Capital), featuring lead investors Relevance Ventures […]
Series A – Patina
On Oct 26, 2021 Patina closed a Series A round and raised $50,000,000 from Andreessen Horowitz, GV, featuring lead investors . About the company: Patina […]
Series A – Anomaly
On Oct 26, 2021 Anomaly closed a Series A round and raised $12,000,000 from Link Ventures, Madrona Venture Group, Redesign Health, RRE Ventures, featuring lead […]
Series B – Onconano Medicine
On Oct 25, 2021 Onconano Medicine closed a Series B round and raised $18,400,000 from Cancer Prevention and Research Institute of Texas, featuring lead investors […]
Series B – Cedilla Therapeutics
On Oct 25, 2021 Cedilla Therapeutics closed a Series B round and raised $25,000,000 from Janus Henderson Investors, Logos Capital, RA Capital Management, Third Rock […]
Series B – Onconano Medicine
On Oct 25, 2021 Onconano Medicine closed a Series B round and raised $18,400,000 from Cancer Prevention and Research Institute of Texas, featuring lead investors […]
